(Total Views: 287)
Posted On: 05/02/2017 12:45:53 PM
Post# of 29744
$APTO Focuses on
Aptose Biosciences, Inc. is a clinical-stage oncology company, which focuses on the discovery, research and development of anticancer therapies. Its product portfolio includes APTO-253, a small molecule that induce expression of the Kruppel-Like Factor 4 (KLF4) genes; and CG'806. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.
Aptose Biosciences, Inc. is a clinical-stage oncology company, which focuses on the discovery, research and development of anticancer therapies. Its product portfolio includes APTO-253, a small molecule that induce expression of the Kruppel-Like Factor 4 (KLF4) genes; and CG'806. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.
(0)
(0)
